Clinical trial
Impact of Specific Antimicrobials and Minimal Inhibitory Concentration(MIC) Values on the Outcome of Bloodstream Infections Due to ESBL or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
NCT01764490 is registered in ClinicalTrials.gov with JESUS RODRIGUEZ BAÑO as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Specific Antimicrobials and Minimal Inhibitory Concentration(MIC) Values on the Outcome of Bloodstream Infections Due to ESBL or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
- Lead sponsor
- JESUS RODRIGUEZ BAÑO
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- May 31, 2014
- Enrollment
- 1,344 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinically significant bacteremia